Atrium Therapeutics (RNA) Free Cash Flow (2025 - 2026)
Atrium Therapeutics (RNA) free cash flow from Mar 31, 2025 to Mar 31, 2026. The TTM Atrium Therapeutics (RNA) free cash flow is -$33M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Quarterly Free Cash Flow
Atrium Therapeutics (RNA) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +199.46% |
Annual Free Cash Flow change of Atrium Therapeutics (RNA)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$33M | +199.46% |
| 2025 | -$11M | N/A |